MAPT and type 2 diabetes mellitus: All these data suggest that in addition to the increase in the protein levels, post-translational modifications of either α-synuclein, Aβ and tau would also play a key role in T2DM pathophysiology and the development of insulin resistance in patients with neurodegenerative diseases.